A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

Clinical trial NCT01154062 · COMPLETED

Trial details

NCT number: NCT01154062
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2010-08-16
Primary completion: 2011-04-29
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.